ENTROLATE
Main information
- Trade name:
- ENTROLATE 10 TAB
- Active ingredient:
- Diloxanide Furoate,Tinidazole
- Available from:
- Stadmed
- Dosage:
- 500,300;MG
- Pharmaceutical form:
- TAB
- Composition:
- 10
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
30-1-2018

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate / vilanterol, Revision: 13, Authorised
Europe - EMA - European Medicines Agency
30-1-2018

Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate / vilanterol, Revision: 11, Authorised
Europe - EMA - European Medicines Agency
26-1-2018

Pending EC decision: Relvar Ellipta, fluticasone furoate / vilanterol, Opinion date: 25-Jan-2018
Europe - EMA - European Medicines Agency
26-1-2018

Pending EC decision: Revinty Ellipta, fluticasone furoate / vilanterol, Opinion date: 25-Jan-2018
Europe - EMA - European Medicines Agency
25-1-2018

Human medicines European public assessment report (EPAR): Elebrato Ellipta, fluticasone furoate / umeclidinium / vilanterol, Revision: 0, Authorised
Europe - EMA - European Medicines Agency
12-1-2018

Human medicines European public assessment report (EPAR): Trelegy Ellipta, fluticasone furoate / umeclidinium / vilanterol, Revision: 0, Authorised
Europe - EMA - European Medicines Agency
27-9-2017

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate / vilanterol, Revision: 11, Authorised
Europe - EMA - European Medicines Agency
26-9-2017

Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate / vilanterol, Revision: 9, Authorised
Europe - EMA - European Medicines Agency
15-9-2017

Pending EC decision: Trelegy Ellipta, fluticasone furoate / umeclidinium / vilanterol, Opinion date: 14-Sep-2017
Europe - EMA - European Medicines Agency
15-9-2017

Pending EC decision: Elebrato Ellipta, fluticasone furoate / umeclidinium / vilanterol , Opinion date: 14-Sep-2017
Europe - EMA - European Medicines Agency
4-9-2017

Human medicines European public assessment report (EPAR): Avamys, fluticasone furoate, Revision: 17, Authorised
Europe - EMA - European Medicines Agency
17-8-2017

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate / vilanterol, Revision: 10, Authorised
Europe - EMA - European Medicines Agency
25-7-2017

Opinion/decision on a Paediatric investigation plan (PIP): -, Indacaterol (acetate) / mometasone (furoate), Therapeutic area: Pneumology-allergology
Europe - EFSA - European Food Safety Authority EFSA Journal
25-7-2017

Opinion/decision on a Paediatric investigation plan (PIP): Relvar Ellipta and associated names, Fluticasone (furoate) / vilanterol, Therapeutic area: Pneumology-allergology
Europe - EFSA - European Food Safety Authority EFSA Journal
4-7-2017

Human medicines European public assessment report (EPAR): Avamys, fluticasone furoate, Revision: 16, Authorised
Europe - EMA - European Medicines Agency
29-6-2017

Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate / vilanterol, Revision: 8, Authorised
Europe - EMA - European Medicines Agency
6-4-2018
![ASMANEX (Mometasone Furoate) Inhalant [Merck Sharp Dohme Corp.]](/web/assets/global/img/flags/us.png)
ASMANEX (Mometasone Furoate) Inhalant [Merck Sharp Dohme Corp.]
Updated Date: Apr 6, 2018 EST
US - DailyMed
6-4-2018
![ASMANEX HFA (Mometasone Furoate) Aerosol [Merck Sharp Dohme Corp.]](/web/assets/global/img/flags/us.png)
ASMANEX HFA (Mometasone Furoate) Aerosol [Merck Sharp Dohme Corp.]
Updated Date: Apr 6, 2018 EST
US - DailyMed
5-4-2018

Dulera (Mometasone Furoate, Formoterol Fumarate Dihydrate Inhalation) - updated on RxList
US - RxList
22-3-2018
![MOMETASONE FUROATE Spray, Metered [REMEDYREPACK INC.]](/web/assets/global/img/flags/us.png)
MOMETASONE FUROATE Spray, Metered [REMEDYREPACK INC.]
Updated Date: Mar 22, 2018 EST
US - DailyMed
20-2-2018

Flagyl vs. Tindamax
Flagyl, Flagyl ER, and Flagyl Injection (metronidazole) and Tindamax (tinidazole) are nitroimidazole antibiotics used to treat bacterial infections. Side effects of Flagyl and Tindamax that are similar include nausea, vomiting, stomach upset, stomach/abdominal cramps/pain, diarrhea, constipation, dizziness, headache, or a bitter or metallic taste in the mouth or changes in taste.
US - RxList
1-2-2018
![SINUVA (Mometasone Furoate) Implant [Intersect ENT, Inc.]](/web/assets/global/img/flags/us.png)
SINUVA (Mometasone Furoate) Implant [Intersect ENT, Inc.]
Updated Date: Feb 1, 2018 EST
US - DailyMed
22-1-2018
![MOMETASONE FUROATE Cream [A-S Medication Solutions]](/web/assets/global/img/flags/us.png)
MOMETASONE FUROATE Cream [A-S Medication Solutions]
Updated Date: Jan 22, 2018 EST
US - DailyMed
16-1-2018
![DULERA (Mometasone Furoate And Formoterol Fumarate Dihydrate) Aerosol [A-S Medication Solutions]](/web/assets/global/img/flags/us.png)
DULERA (Mometasone Furoate And Formoterol Fumarate Dihydrate) Aerosol [A-S Medication Solutions]
Updated Date: Jan 16, 2018 EST
US - DailyMed
8-1-2018
![BREO ELLIPTA (Fluticasone Furoate And Vilanterol Trifenatate) Powder [GlaxoSmithKline LLC]](/web/assets/global/img/flags/us.png)
BREO ELLIPTA (Fluticasone Furoate And Vilanterol Trifenatate) Powder [GlaxoSmithKline LLC]
Updated Date: Jan 8, 2018 EST
US - DailyMed
8-1-2018
![BREO ELLIPTA (Fluticasone Furoate And Vilanterol Trifenatate) Powder [Glaxo Operations UK Ltd]](/web/assets/global/img/flags/us.png)
BREO ELLIPTA (Fluticasone Furoate And Vilanterol Trifenatate) Powder [Glaxo Operations UK Ltd]
Updated Date: Jan 8, 2018 EST
US - DailyMed
2-1-2018
![MOMETASONE FUROATE Ointment [A-S Medication Solutions]](/web/assets/global/img/flags/us.png)
MOMETASONE FUROATE Ointment [A-S Medication Solutions]
Updated Date: Jan 2, 2018 EST
US - DailyMed
29-12-2017
![MOMETASONE FUROATE Spray, Metered [Golden State Medical Supply, Inc.]](/web/assets/global/img/flags/us.png)
MOMETASONE FUROATE Spray, Metered [Golden State Medical Supply, Inc.]
Updated Date: Dec 29, 2017 EST
US - DailyMed
20-12-2017
![NASONEX (Mometasone Furoate Monohydrate) Spray, Metered [Merck Sharp Dohme Corp.]](/web/assets/global/img/flags/us.png)
NASONEX (Mometasone Furoate Monohydrate) Spray, Metered [Merck Sharp Dohme Corp.]
Updated Date: Dec 20, 2017 EST
US - DailyMed
13-12-2017
![TINDAZOLE (Tinidazole) Tablet, Film Coated [Rising Pharmaceuticals, Inc.]](/web/assets/global/img/flags/us.png)
TINDAZOLE (Tinidazole) Tablet, Film Coated [Rising Pharmaceuticals, Inc.]
Updated Date: Dec 13, 2017 EST
US - DailyMed
8-12-2017

Flovent Diskus vs. Asmanex
Flovent (fluticasone propionate) and Asmanex HFA (mometasone furoate) are steroids used to prevent asthma attacks.
US - RxList
5-12-2017

Flovent vs. Asmanex
Flovent (fluticasone propionate) and Asmanex HFA (mometasone furoate) are steroids used to prevent asthma attacks.
US - RxList
22-11-2017
![MOMETASONE FUROATE Cream [Harris Pharmaceutical, Inc.]](/web/assets/global/img/flags/us.png)
MOMETASONE FUROATE Cream [Harris Pharmaceutical, Inc.]
Updated Date: Nov 22, 2017 EST
US - DailyMed
17-11-2017

Elebrato Ellipta (GlaxoSmithKline Trading Services Limited)
Elebrato Ellipta (Active substance: fluticasone furoate/umeclidinium/vilanterol) - Centralised - Authorisation - Commission Decision (2017)7745 of Fri, 17 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4781
Europe -DG Health and Food Safety
17-11-2017

Trelegy Ellipta (GlaxoSmithKline Trading Services Limited)
Trelegy Ellipta (Active substance: fluticasone furoate/umeclidinium/vilanterol) - Centralised - Authorisation - Commission Decision (2017)7744 of Fri, 17 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4363
Europe -DG Health and Food Safety
25-10-2017
![MOMETAMAX (Gentamicin Sulfate, Mometasone Furoate Monohydrate, And Clotrimazole) Suspension [Merck Sharp Dohme Corp.]](/web/assets/global/img/flags/us.png)
MOMETAMAX (Gentamicin Sulfate, Mometasone Furoate Monohydrate, And Clotrimazole) Suspension [Merck Sharp Dohme Corp.]
Updated Date: Oct 25, 2017 EST
US - DailyMed
25-10-2017
![MOTAZOL (Gentamicin Sulfate, Mometasone Furoate Monohydrate, And Clotrimazole) Suspension [MWI]](/web/assets/global/img/flags/us.png)
MOTAZOL (Gentamicin Sulfate, Mometasone Furoate Monohydrate, And Clotrimazole) Suspension [MWI]
Updated Date: Oct 25, 2017 EST
US - DailyMed
23-10-2017
![MOMETASONE FUROATE Ointment [Perrigo New York Inc]](/web/assets/global/img/flags/us.png)
MOMETASONE FUROATE Ointment [Perrigo New York Inc]
Updated Date: Oct 23, 2017 EST
US - DailyMed
18-10-2017
![TINIDAZOLE Tablet [Lupin Pharmaceuticals,Inc.]](/web/assets/global/img/flags/us.png)
TINIDAZOLE Tablet [Lupin Pharmaceuticals,Inc.]
Updated Date: Oct 18, 2017 EST
US - DailyMed
25-9-2017

Revinty Ellipta (Glaxo Group Ltd)
Revinty Ellipta (Active substance: fluticasone furoate / vilanterol trifenatate) - Centralised - Yearly update - Commission Decision (2017)6510 of Mon, 25 Sep 2017
Europe -DG Health and Food Safety
25-9-2017

Relvar Ellipta (Glaxo Group Ltd)
Relvar Ellipta (Active substance: fluticasone furoate/vilanterol trifenatate) - Centralised - Yearly update - Commission Decision (2017)6508 of Mon, 25 Sep 2017
Europe -DG Health and Food Safety
20-9-2017

FDA Approves Trelegy Ellipta for COPD
The US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta, GlaxoSmithKline) for patients with chronic obstructive pulmonary disease (COPD).
US - RxList
19-9-2017
![TRELEGY ELLIPTA (Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate) Powder [GlaxoSmithKline LLC]](/web/assets/global/img/flags/us.png)
TRELEGY ELLIPTA (Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate) Powder [GlaxoSmithKline LLC]
Updated Date: Sep 19, 2017 EST
US - DailyMed
28-7-2017
![DULERA (Mometasone Furoate And Formoterol Fumarate Dihydrate) Aerosol [Merck Sharp Dohme Corp.]](/web/assets/global/img/flags/us.png)
DULERA (Mometasone Furoate And Formoterol Fumarate Dihydrate) Aerosol [Merck Sharp Dohme Corp.]
Updated Date: Jul 28, 2017 EST
US - DailyMed
25-7-2017
![MOMETASONE FUROATE Cream [NuCare Pharmaceuticals,Inc.]](/web/assets/global/img/flags/us.png)
MOMETASONE FUROATE Cream [NuCare Pharmaceuticals,Inc.]
Updated Date: Jul 25, 2017 EST
US - DailyMed
8-6-2017
![MOMETASONE FUROATE (Mometasone) Spray, Metered [AvKARE, Inc.]](/web/assets/global/img/flags/us.png)
MOMETASONE FUROATE (Mometasone) Spray, Metered [AvKARE, Inc.]
Updated Date: Jun 8, 2017 EST
US - DailyMed
2-6-2017
![MOMETASONE FUROATE Spray, Metered [Apotex Corp.]](/web/assets/global/img/flags/us.png)
MOMETASONE FUROATE Spray, Metered [Apotex Corp.]
Updated Date: Jun 2, 2017 EST
US - DailyMed
26-5-2017

Breo Ellipta (Fluticasone Furoate and Vilanterol Inhalation Powder) - updated on RxList
US - RxList
23-5-2017
![MOMETASONE FUROATE (Mometasone Furoate) Cream [A-S Medication Solutions]](/web/assets/global/img/flags/us.png)
MOMETASONE FUROATE (Mometasone Furoate) Cream [A-S Medication Solutions]
Updated Date: May 23, 2017 EST
US - DailyMed
22-5-2017
![ARNUITY ELLIPTA (Fluticasone Furoate) Powder [GlaxoSmithKline LLC]](/web/assets/global/img/flags/us.png)
ARNUITY ELLIPTA (Fluticasone Furoate) Powder [GlaxoSmithKline LLC]
Updated Date: May 22, 2017 EST
US - DailyMed